UnitedHealth Group (NYSE:UNH) Price Target Raised to $516.00 at JPMorgan Chase & Co.

UnitedHealth Group (NYSE:UNH) had its price objective raised by JPMorgan Chase & Co. from $466.00 to $516.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the healthcare conglomerate’s stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 19.29% from the company’s current price.

A number of other equities analysts have also recently issued reports on the stock. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $468.00 to $529.00 and gave the stock an “overweight” rating in a research report on Friday. KeyCorp upped their price target on UnitedHealth Group from $400.00 to $475.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Erste Group Bank raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, April 27th. HC Wainwright set a $492.00 target price on UnitedHealth Group in a research report on Wednesday, May 27th. Finally, Jefferies Financial Group lifted their price target on shares of UnitedHealth Group from $340.00 to $373.00 and gave the company a “buy” rating in a research report on Monday, April 20th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $455.92.

UnitedHealth Group Trading Up 2.6%

Shares of UNH stock traded up $10.99 during trading hours on Tuesday, hitting $432.54. 1,293,705 shares of the company were exchanged, compared to its average volume of 8,420,451. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.80 and a current ratio of 0.78. UnitedHealth Group has a fifty-two week low of $234.60 and a fifty-two week high of $461.62. The company has a 50 day simple moving average of $405.55 and a two-hundred day simple moving average of $343.00. The firm has a market cap of $392.81 billion, a P/E ratio of 27.85, a P/E/G ratio of 1.67 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. During the same period in the prior year, the firm earned $4.08 earnings per share. UnitedHealth Group’s revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities analysts anticipate that UnitedHealth Group will post 18.77 EPS for the current year.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.19% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in UNH. Ares Financial Consulting LLC grew its stake in shares of UnitedHealth Group by 7.2% during the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock valued at $174,000 after acquiring an additional 28 shares during the period. Kellett Wealth Advisors LLC lifted its holdings in UnitedHealth Group by 1.7% during the fourth quarter. Kellett Wealth Advisors LLC now owns 1,746 shares of the healthcare conglomerate’s stock valued at $576,000 after purchasing an additional 29 shares in the last quarter. Founders Capital Management LLC increased its stake in shares of UnitedHealth Group by 3.0% in the fourth quarter. Founders Capital Management LLC now owns 982 shares of the healthcare conglomerate’s stock worth $324,000 after purchasing an additional 29 shares in the last quarter. Rockland Trust Co. lifted its stake in shares of UnitedHealth Group by 1.1% during the 2nd quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate’s stock valued at $1,076,000 after buying an additional 29 shares in the last quarter. Finally, Matrix Trust Co boosted its holdings in UnitedHealth Group by 24.8% in the 2nd quarter. Matrix Trust Co now owns 146 shares of the healthcare conglomerate’s stock worth $61,000 after buying an additional 29 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Several analysts and commentators highlighted UnitedHealth’s strong quarterly performance and see room for further upside, with some price targets lifted to around $500 after the company “handily” beat expectations. UnitedHealth Stock: Is It Headed for $500?
• Positive Sentiment: UnitedHealth announced a $5 billion share buyback, which investors may view as a sign of confidence in cash flow and the company’s recovery outlook. A $5 Billion Reason to Buy UnitedHealth Stock Here
• Positive Sentiment: Barclays raised its price target on UNH to $441 and kept an overweight rating, reinforcing the bullish analyst tone around the stock. Benzinga report on Barclays price target increase
• Positive Sentiment: More media coverage calling UNH a high-dividend and momentum stock is adding to the view that it remains a defensive, quality name for investors seeking stable earnings and cash flow. 5 High Dividend Yield Stocks to Buy for a Stable Portfolio in 2H 2026
• Neutral Sentiment: Congress passed a bill aimed at increasing provider accountability and fraud oversight in FECA, which could raise compliance scrutiny for large healthcare companies, but the direct financial impact on UNH is unclear. Congress Vote: The House has passed H.R. 8823

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.